skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > oxopurine > 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide

Preferred term

2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-n-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C23H24N6O6S

inchi

  • InChI=1S/C23H24N6O6S/c1-14-5-6-16(11-18(14)36(33,34)26-15-7-9-17(35-4)10-8-15)25-19(30)12-29-13-24-21-20(29)22(31)28(3)23(32)27(21)2/h5-11,13,26H,12H2,1-4H3,(H,25,30)

inchikey

  • PNLVXTUTMBHOGP-UHFFFAOYSA-N

mass

  • 512.540

monoisotopicmass

  • 512.14780

smiles

  • CC1=C(C=C(C=C1)NC(=O)CN2C=NC3=C2C(=O)N(C(=O)N3C)C)S(=O)(=O)NC4=CC=C(C=C4)OC

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:116898

Download this concept:

RDF/XML TURTLE JSON-LD